Jump to content

Jeff Radwell

From Wikipedia, the free encyclopedia
Jeff Radwell
Born
Jeffrey Leo Radwell
NationalityAmerican
EducationUniversity of Pennsylvania (BA)

London Business School (MBA)

Imperial College London (PhD)
Known forCEO and founder of Camouflet
Scientific career
FieldsImmunology, molecular biology
InstitutionsImperial College London, New York University
Thesis Molecular Basis of Chronic Inflammation-Driven Tumorigenesis: Modulation of NF-κB and STAT3 Signaling Pathways

Jeff Radwell (born 1990) is an American research scientist who is the founder and CEO of Camouflet, a Los Angeles based software startup specializing in pricing solutions powered by artificial intelligence (AI).[1]

Early life and education

[edit]

Radwell was raised near Philadelphia, PA in a family of educators. He also spent part of his childhood in the Chinese city of Guangzhou and special administrative regions of Hong Kong and Macau. He attended the George School.

He holds an undergraduate degree from the University of Pennsylvania, a Master of Business Administration from London Business School, and a Doctor of Philosophy from the Imperial College London Faculty of Medicine.[2]

Radwell is actively engaged in philanthropic initiatives, with a primary focus on supporting educational causes. His contributions to the Stanley Primary School's "Living Classroom" earned recognition at the prestigious 2016 Royal Horticultural Society Chelsea Flower Show, earning the Silver-Gilt Medal.[3][4] Radwell also serves as a sponsor of the Point Foundation, an organization dedicated to providing college scholarships to LGBTQ+ students. [5][6] His involvement reflects his personal commitment to supporting community development, diversity, inclusion, and the promotion of equal opportunities for students from marginalized backgrounds.

Career

[edit]

Early career

[edit]

Beginning his academic career at the New York University Grossman School of Medicine,[7] Radwell focused his research on applying real-world data and machine learning algorithms to address significant public health questions amid the height of the COVID-19 pandemic.[8] This work was supported by funding from the National Institutes of Health (NIH), which provided resources in building operational infrastructure to facilitate the study's objectives through advanced data analysis.[9]

Radwell's efforts in developing novel machine learning algorithms and use of multivariate statistical methodologies led to the creation of the first computable phenotype for Long COVID, contributing to its formal definition.[10][11] His analytical approach harmonized data from three research networks within the NIH's "REsearching COVID to Enhance Recovery" (RECOVER) initiative: PCORnet Adult of Weill Cornell Medicine and PCORnet Pediatric of the Children's Hospital of Philadelphia, both funded by the Patient-Centered Outcomes Research Institute (PCORI), and the National COVID Cohort Collaborative (N3C), overseen by the National Center for Advancing Translational Sciences (NCATS).[12] The RECOVER Initiative is a $1.7 billion national research program focused on advancing the understanding, treatment, and prevention of Long COVID across the United States.[13][14]

Camouflet

[edit]

In 2024, Radwell founded Camouflet, a company whose flagship platform uses AI-driven analytics to respond to market fluctuations in real-time. Radwell's vision for Camouflet was shaped by his research background and extensive experience in data analytics."[1]

Personal life

[edit]

Radwell lives in the Los Feliz neighborhood of Los Angeles, California.[15]

References

[edit]
  1. ^ a b "Camouflet Unveils Next-Generation Dynamic Pricing Platform to Transform Market Competitiveness and Profitability". Yahoo Finance.
  2. ^ Yahoo Finance (November 4, 2024). "Camouflet Unveils Next-Generation Dynamic Pricing Platform to Transform Market Competitiveness and Profitability". Yahoo Finance.
  3. ^ "Stanley Primary School News". Stanley Primary School.
  4. ^ "About RHS Awards and Medals". RHS: Chelsea Flower Show. Royal Horticultural Society.
  5. ^ "What We Do". Point Foundation.
  6. ^ "2021 Annual Report" (PDF). 20 Years of the Point Foundation: The National LGBTQ Scholarship Fund. Point Foundation.
  7. ^ Williams, Greg. "Sleep Apnea Associated with Increased Risk for Long COVID". NYU Langone Health.
  8. ^ Mandel, Hannah (May 11, 2023). "Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health record-based analysis from the RECOVER initiative". Sleep. 46 (9). doi:10.1093/sleep/zsad126. PMC 10485569. PMID 37166330.
  9. ^ "Breathing Uneasy: Sleep Apnea Linked With Increased Long COVID Risks". SciTechDaily. May 11, 2023.
  10. ^ "Sleep apnea associated with increased risk for long COVID: Study suggests physicians may need to follow patients with both conditions more closely". Newswise. May 11, 2023.
  11. ^ Pfaff, Emily (May 16, 2022). "Identifying who has long COVID in the USA: a machine learning approach using N3C data" (PDF). The Lancet. 4. PMID 35589549.
  12. ^ l Mandel, H.; et al. (2023). "Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health record-based analysis from the RECOVER initiative". Sleep. 46 (9). Johns Hopkins University. doi:10.1093/sleep/zsad126. PMC 10485569. PMID 37166330.
  13. ^ "HHS Announces the Formation of the Office of Long COVID Research and Practice and Launch of Long COVID Clinical Trials Through the RECOVER Initiative". U.S. Department of Health and Human Services.
  14. ^ "NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million". Recover COVID. National Institutes of Health.
  15. ^ "2024 Harvard Club Annual Meeting and Awards Dinner". Harvard Club of Southern California. Harvard Alumni Association.